Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
M. Ojinga Harrison, MD: Antipsychotic Medications and Sudden Cardiac Death
1
x
$
30.00
Raising the Bar From Response to Remission in the Therapy of Generalized Anxiety Disorder
1
x
$
10.00
Contemporary Management of Alzheimer’s Disease
1
x
$
30.00
Effect of Milnacipran on Plasma Level of Vascular Endothelial Growth Factor in Major Depression
1
x
$
30.00
David V. Sheehan, MD, MBA: The Speed of Onset of Action of Alprazolam-XR Compared to Alprazolam-CT in Panic Disorder
1
x
$
30.00
Todd Lencz, PhD: Neurodevelopmental Models of Schizophrenia: Pathophysiologic Synthesis and Directions for Intervention Research
1
x
$
30.00
View Cart
Checkout
Home
Store
You cannot add another "Raising the Bar From Response to Remission in the Therapy of Generalized Anxiety Disorder" to your cart.
View cart
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Efficacy and Tolerability of Two Different Kinds of Titration of Paroxetine Hydrocloride Solution: an Observational Study
$
30.00
Add to cart
Details
Characterizing the Effects of Quetiapine in Military Post-Traumatic Stress Disorder
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 48 No. 1, 2018 – Full Issue Stacked PDF
$
90.00
Add to cart
Details
Effective Vortioxetine Dose Varies with Extent of Antidepressant Use Across Countries
$
30.00
Add to cart
Details
Major Depression Comorbid with Medical Conditions: Analysis of Quality of Life, Functioning, and Depressive Symptom Severity
$
30.00
Add to cart
Details
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder
$
0.00
Add to cart
Details
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
$
0.00
Add to cart
Details
Psychopharmacology Bulletin VOL 47 No. 1, 2017 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
Treatment of Autism Spectrum Disorder in Children and Adolescents
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 36 Supplement No. 1 – Full Issue Stacked PDF
$
0.00
Add to cart
Details
New Strategies for the Treatment of Indolent Non-Hodgkin’s Lymphomas
$
0.00
Add to cart
Details
A Major Change of Prescribing Pattern in Absence of Adequate Evidence: Benzodiazepines Versus Newer Antidepressants in Anxiety Disorders
$
30.00
Add to cart
Details
The Sex Effects Scale: Pilot Validation in a Healthy Population
$
30.00
Add to cart
Details
Switching from Other Agents to Extended-Release Carbamazepine in Acute Mania
$
30.00
Add to cart
Details
Efficacy of Duloxetine for the Treatment of Depression: Relationship to Most Recent Antidepressant Trial
$
30.00
Add to cart
Details
Paul E. Holtzheimer III, MD: A Meta-analysis of Repetitive Transcranial Magnetic Stimulation in the Treatment of Depression
$
30.00
Add to cart
Details
Deanna L. Kelly, PharmD, BCPP: Ziprasidone and the QTc Interval: Pharmacokinetic and Pharmacodynamic Considerations
$
30.00
Add to cart
Details
Estudio de validación de la Escala de Salud Personal (ESP) en Lima, Perú
$
0.00
Add to cart
Details
C. Lindsay DeVane, PharmD: Clinical Significance of Drug Binding, Protein Binding, and Binding Displacement Drug Interactions
$
30.00
Add to cart
Details
James H. Kocsis, MD: Continuation Treatment of Chronic Depression: A Comparison of Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, and Their Combination
$
30.00
Add to cart
Details
Previous
1
…
10
11
12
…
44
Next
Page load link
Go to Top
